Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Change in Accured Expenses: 2009-2024

Historic Change in Accured Expenses for Pediatrix Medical (MD) over the last 16 years, with FY2024 value amounting to $51.1 million.

  • Pediatrix Medical's Change in Accured Expenses rose 482.95% to $51.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$198.5 million, marking a year-over-year decrease of 1304.03%. This contributed to the annual value of $51.1 million for FY2024, which is 27938.82% up from last year.
  • Per Pediatrix Medical's latest filing, its Change in Accured Expenses stood at $51.1 million for FY2024, which was up 27938.82% from -$28.5 million recorded in FY2023.
  • Over the past 5 years, Pediatrix Medical's Change in Accured Expenses peaked at $51.1 million during FY2024, and registered a low of -$28.5 million during FY2023.
  • Over the past 5 years, Pediatrix Medical's median Change in Accured Expenses value was -$20.0 million (recorded in 2022), while the average stood at $5.6 million.
  • As far as peak fluctuations go, Pediatrix Medical's Change in Accured Expenses crashed by 14702.55% in 2021, and later skyrocketed by 27938.82% in 2024.
  • Over the past 5 years, Pediatrix Medical's Change in Accured Expenses (Annual) stood at $47.9 million in 2020, then crashed by 147.03% to -$22.5 million in 2021, then grew by 11.23% to -$20.0 million in 2022, then plummeted by 42.55% to -$28.5 million in 2023, then skyrocketed by 279.39% to $51.1 million in 2024.
  • Its Change in Accured Expenses was $51.1 million in FY2024, compared to -$28.5 million in FY2023 and -$20.0 million in FY2022.